title: Further Electrochemical and Behavioural Evidence of a Direct Relationship Between Central 5-HT and Cytoskeleton in the Control of Mood.
abstract: Reduced activity of CNS serotonin is reported in unipolar depression and serotonin is the major target of recent antidepressant drugs. However, an acute depletion of serotonin in healthy individuals does not induce depressive symptoms suggesting that depression does not correlate with the serotonin system only. Neuronal plasticity (structural adaptation of neurons to functional requirements) includes synthesis of microtubular proteins such as tyrosinated isoform of alpha-tubulin and presence of serotonin as regulator of synaptogenesis. In depression neuronal plasticity is modified.HERE, IN RATS SUBMITTED TO A BEHAVIOURAL TEST WIDELY USED TO PREDICT THE EFFICACY OF ANTIDEPRESSANT DRUGS (FORCED SWIMMING TEST: FST) a significant decrease of both cerebral tyrosinated alpha-tubulin expression and serotonin levels is monitored. Moreover, treatment with para-chlorophenylalanine (PCPA, compound that specifically depletes brain serotonin) but not alpha-methyl para tyrosine (alpha-MPT, compound that blocks synthesis of catechols: chemicals also implicated in depression) significantly reduced tyrosinated alpha-tubulin. Thus, a direct relationship between serotonin and tyrosinated alpha-tubulin appears to be present both in "physiological" and in "pathological" states. In addition, data obtained in animals submitted to FST and/or treated with the selective serotonin reuptake inhibitor (SSRI) fluoxetine further support the interrelationship between central serotonin and cytoskeleton. These data propose that direct relationship between serotonin and tyrosinated alpha-tubulin could be considered within the mechanism(s) involved in the pathogenesis of depression.
authors.affiliation: Biology Department, Neurosciences CEDD GlaxoSmithKline, Medicines Research Centre, via Fleming 4, 37135 Verona, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Crespi
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1136-43
references.pmid: 16797263
references.citation: Pharmacol Biochem Behav. 1995 Sep;52(1):107-12
references.pmid: 7501651
references.citation: Behav Brain Res. 2009 Dec 28;205(2):518-24
references.pmid: 19683020
references.citation: Hum Psychopharmacol. 2008 Dec;23(8):647-51
references.pmid: 18821727
references.citation: J Neurosci Methods. 1994 Sep;54(1):75-82
references.pmid: 7815821
references.citation: J Neurosci Methods. 1990 Sep;34(1-3):53-65
references.pmid: 1979651
references.citation: J Pharmacol Exp Ther. 1966 Dec;154(3):499-516
references.pmid: 5297133
references.citation: Neuromolecular Med. 2004;5(1):11-25
references.pmid: 15001809
references.citation: Neurochem Res. 2007 Sep;32(9):1559-65
references.pmid: 17486443
references.citation: Biol Psychiatry. 2000 Oct 15;48(8):732-9
references.pmid: 11063970
references.citation: J Cell Biol. 1984 Jan;98(1):347-51
references.pmid: 6707095
references.citation: J Affect Disord. 2006 Oct;95(1-3):119-23
references.pmid: 16782204
references.citation: Ann N Y Acad Sci. 1990;600:297-313; discussion 314
references.pmid: 2252317
references.citation: Sensors (Basel). 2008 Nov 04;8(11):6936-6951
references.pmid: 27873908
references.citation: Brain Res. 2003 Jun 13;975(1-2):244-7
references.pmid: 12763614
references.citation: Neuropsychopharmacology. 1994 Jul;10(4):231-8
references.pmid: 7945733
references.citation: Nucl Med Biol. 1999 Jan;26(1):91-8
references.pmid: 10096507
references.citation: Psychopharmacology (Berl). 2006 Jun;186(3):362-72
references.pmid: 16432684
references.citation: Hum Psychopharmacol. 2004 Aug;19(6):405-8
references.pmid: 15303244
references.citation: Int Rev Cytol. 1989;114:21-79
references.pmid: 2661457
references.citation: Hum Psychopharmacol. 2000 Jul;15(5):315-336
references.pmid: 12404310
references.citation: J Neurochem. 1992 Jan;58(1):250-7
references.pmid: 1370077
references.citation: Cell. 1991 Feb 22;64(4):817-26
references.pmid: 1997209
references.citation: Psychopharmacology (Berl). 2003 Jan;165(2):97-110
references.pmid: 12420152
references.citation: Biol Psychiatry. 2006 Feb 15;59(4):309-16
references.pmid: 16154542
references.citation: Behav Brain Res. 1996;73(1-2):43-6
references.pmid: 8788475
references.citation: Neuroscience. 1988 Dec;27(3):885-96
references.pmid: 3252175
references.citation: Psychopharmacology (Berl). 1986;89(4):467-71
references.pmid: 2428076
references.citation: J Cell Biol. 1987 Jul;105(1):251-64
references.pmid: 2886509
references.citation: Neurosci Lett. 2001 Oct 12;312(1):5-8
references.pmid: 11578832
references.citation: FEBS Lett. 2003 Jan 30;535(1-3):183-9
references.pmid: 12560101
references.citation: Synapse. 1999 Mar 15;31(4):285-9
references.pmid: 10051109
references.citation: J Neurosci. 2003 Aug 6;23(18):6972-81
references.pmid: 12904458
references.citation: Curr Opin Cell Biol. 1994 Feb;6(1):74-81
references.pmid: 8167029
references.citation: Psychopharmacology (Berl). 1995 Sep;121(1):66-72
references.pmid: 8539342
references.citation: Nature. 1977 Apr 21;266(5604):730-2
references.pmid: 559941
references.citation: Eur J Pharmacol. 1997 Aug 27;333(2-3):279-87
references.pmid: 9314045
references.citation: Biochem J. 1999 Apr 15;339 ( Pt 2):463-71
references.pmid: 10191280
references.citation: Neurochem Res. 2000 Jan;25(1):27-36
references.pmid: 10685601
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4711-6
references.pmid: 16537405
references.citation: Prog Neurobiol. 2003 Dec;71(6):401-37
references.pmid: 15013227
references.citation: Biol Psychiatry. 2008 Aug 15;64(4):293-301
references.pmid: 18406399
references.citation: Eur J Pharmacol. 1997 Oct 15;337(1):111-4
references.pmid: 9389388
references.citation: Rev Neurosci. 2005;16(1):23-41
references.pmid: 15810652
references.citation: Science. 1985 Oct 11;230(4722):181-3
references.pmid: 3875898
references.citation: Trends Pharmacol Sci. 1994 Jul;15(7):220-6
references.pmid: 7940983
references.citation: Eur J Histochem. 1999;43(4):285-91
references.pmid: 10682266
references.citation: Crit Rev Neurobiol. 2004;16(1-2):67-74
references.pmid: 15581401
references.citation: Int J Neuropsychopharmacol. 2005 Mar;8(1):1-4
references.pmid: 15710052
references.citation: Biol Psychiatry. 2004 Aug 1;56(3):140-5
references.pmid: 15271581
references.citation: Int Rev Cytol. 1998;178:207-75
references.pmid: 9348671
references.citation: Schizophr Res. 1998 Mar 10;30(2):115-25
references.pmid: 9549774
references.citation: J Neurochem. 2000 Jan;74(1):21-33
references.pmid: 10617102
references.citation: Psychopharmacology (Berl). 1990;100(4):509-14
references.pmid: 2320712
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):169-92
references.pmid: 15694225